[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 DNA Vaccine Market - Global Outlook and Forecast 2021-2027

April 2021 | 90 pages | ID: CA596A487B85EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of COVID-19 DNA Vaccine in Global, including the following market information:

Global COVID-19 DNA Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global COVID-19 DNA Vaccine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 DNA Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 DNA Vaccine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global COVID-19 DNA Vaccine Market Segment Percentages, By Type, 2020 (%)
  • Being Developed
  • Preclinical
  • Clinical I
  • Clinical II
China COVID-19 DNA Vaccine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China COVID-19 DNA Vaccine Market Segment Percentages, By Application, 2020 (%)
  • Pharmaceutical And Biotechnology Companies
  • Hospital
  • Academic And Research Organizations
  • Other
Global COVID-19 DNA Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global COVID-19 DNA Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total COVID-19 DNA Vaccine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total COVID-19 DNA Vaccine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • LineaRx
  • Inovio Pharmaceuticals
  • Zydus Cadila
  • Kangtai Biological
  • Advaccine
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 COVID-19 DNA Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global COVID-19 DNA Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 DNA VACCINE OVERALL MARKET SIZE

2.1 Global COVID-19 DNA Vaccine Market Size: 2021 VS 2027
2.2 Global COVID-19 DNA Vaccine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top COVID-19 DNA Vaccine Players in Global Market
3.2 Top Global COVID-19 DNA Vaccine Companies Ranked by Revenue
3.3 Global COVID-19 DNA Vaccine Revenue by Companies
3.4 Top 3 and Top 5 COVID-19 DNA Vaccine Companies in Global Market, by Revenue in 2020
3.5 Global Companies COVID-19 DNA Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 COVID-19 DNA Vaccine Players in Global Market
  3.6.1 List of Global Tier 1 COVID-19 DNA Vaccine Companies
  3.6.2 List of Global Tier 2 and Tier 3 COVID-19 DNA Vaccine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global COVID-19 DNA Vaccine Market Size Markets, 2021 & 2027
  4.1.2 Being Developed
  4.1.3 Preclinical
  4.1.4 Clinical I
  4.1.5 Clinical II
4.2 By Type - Global COVID-19 DNA Vaccine Revenue & Forecasts
  4.2.1 By Type - Global COVID-19 DNA Vaccine Revenue, 2016-2021
  4.2.2 By Type - Global COVID-19 DNA Vaccine Revenue, 2022-2027
  4.2.3 By Type - Global COVID-19 DNA Vaccine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global COVID-19 DNA Vaccine Market Size, 2021 & 2027
  5.1.2 Pharmaceutical And Biotechnology Companies
  5.1.3 Hospital
  5.1.4 Academic And Research Organizations
  5.1.5 Other
5.2 By Application - Global COVID-19 DNA Vaccine Revenue & Forecasts
  5.2.1 By Application - Global COVID-19 DNA Vaccine Revenue, 2016-2021
  5.2.2 By Application - Global COVID-19 DNA Vaccine Revenue, 2022-2027
  5.2.3 By Application - Global COVID-19 DNA Vaccine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global COVID-19 DNA Vaccine Market Size, 2021 & 2027
6.2 By Region - Global COVID-19 DNA Vaccine Revenue & Forecasts
  6.2.1 By Region - Global COVID-19 DNA Vaccine Revenue, 2016-2021
  6.2.2 By Region - Global COVID-19 DNA Vaccine Revenue, 2022-2027
  6.2.3 By Region - Global COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America COVID-19 DNA Vaccine Revenue, 2016-2027
  6.3.2 US COVID-19 DNA Vaccine Market Size, 2016-2027
  6.3.3 Canada COVID-19 DNA Vaccine Market Size, 2016-2027
  6.3.4 Mexico COVID-19 DNA Vaccine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe COVID-19 DNA Vaccine Revenue, 2016-2027
  6.4.2 Germany COVID-19 DNA Vaccine Market Size, 2016-2027
  6.4.3 France COVID-19 DNA Vaccine Market Size, 2016-2027
  6.4.4 U.K. COVID-19 DNA Vaccine Market Size, 2016-2027
  6.4.5 Italy COVID-19 DNA Vaccine Market Size, 2016-2027
  6.4.6 Russia COVID-19 DNA Vaccine Market Size, 2016-2027
  6.4.7 Nordic Countries COVID-19 DNA Vaccine Market Size, 2016-2027
  6.4.8 Benelux COVID-19 DNA Vaccine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia COVID-19 DNA Vaccine Revenue, 2016-2027
  6.5.2 China COVID-19 DNA Vaccine Market Size, 2016-2027
  6.5.3 Japan COVID-19 DNA Vaccine Market Size, 2016-2027
  6.5.4 South Korea COVID-19 DNA Vaccine Market Size, 2016-2027
  6.5.5 Southeast Asia COVID-19 DNA Vaccine Market Size, 2016-2027
  6.5.6 India COVID-19 DNA Vaccine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America COVID-19 DNA Vaccine Revenue, 2016-2027
  6.6.2 Brazil COVID-19 DNA Vaccine Market Size, 2016-2027
  6.6.3 Argentina COVID-19 DNA Vaccine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa COVID-19 DNA Vaccine Revenue, 2016-2027
  6.7.2 Turkey COVID-19 DNA Vaccine Market Size, 2016-2027
  6.7.3 Israel COVID-19 DNA Vaccine Market Size, 2016-2027
  6.7.4 Saudi Arabia COVID-19 DNA Vaccine Market Size, 2016-2027
  6.7.5 UAE COVID-19 DNA Vaccine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 LineaRx
  7.1.1 LineaRx Corporate Summary
  7.1.2 LineaRx Business Overview
  7.1.3 LineaRx COVID-19 DNA Vaccine Major Product Offerings
  7.1.4 LineaRx COVID-19 DNA Vaccine Revenue in Global (2016-2021)
  7.1.5 LineaRx Key News
7.2 Inovio Pharmaceuticals
  7.2.1 Inovio Pharmaceuticals Corporate Summary
  7.2.2 Inovio Pharmaceuticals Business Overview
  7.2.3 Inovio Pharmaceuticals COVID-19 DNA Vaccine Major Product Offerings
  7.2.4 Inovio Pharmaceuticals COVID-19 DNA Vaccine Revenue in Global (2016-2021)
  7.2.5 Inovio Pharmaceuticals Key News
7.3 Zydus Cadila
  7.3.1 Zydus Cadila Corporate Summary
  7.3.2 Zydus Cadila Business Overview
  7.3.3 Zydus Cadila COVID-19 DNA Vaccine Major Product Offerings
  7.3.4 Zydus Cadila COVID-19 DNA Vaccine Revenue in Global (2016-2021)
  7.3.5 Zydus Cadila Key News
7.4 Kangtai Biological
  7.4.1 Kangtai Biological Corporate Summary
  7.4.2 Kangtai Biological Business Overview
  7.4.3 Kangtai Biological COVID-19 DNA Vaccine Major Product Offerings
  7.4.4 Kangtai Biological COVID-19 DNA Vaccine Revenue in Global (2016-2021)
  7.4.5 Kangtai Biological Key News
7.5 Advaccine
  7.5.1 Advaccine Corporate Summary
  7.5.2 Advaccine Business Overview
  7.5.3 Advaccine COVID-19 DNA Vaccine Major Product Offerings
  7.5.4 Advaccine COVID-19 DNA Vaccine Revenue in Global (2016-2021)
  7.5.5 Advaccine Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. COVID-19 DNA Vaccine Market Opportunities & Trends in Global Market
Table 2. COVID-19 DNA Vaccine Market Drivers in Global Market
Table 3. COVID-19 DNA Vaccine Market Restraints in Global Market
Table 4. Key Players of COVID-19 DNA Vaccine in Global Market
Table 5. Top COVID-19 DNA Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global COVID-19 DNA Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global COVID-19 DNA Vaccine Revenue Share by Companies, 2016-2021
Table 8. Global Companies COVID-19 DNA Vaccine Product Type
Table 9. List of Global Tier 1 COVID-19 DNA Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COVID-19 DNA Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global COVID-19 DNA Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - COVID-19 DNA Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - COVID-19 DNA Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global COVID-19 DNA Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - COVID-19 DNA Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - COVID-19 DNA Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global COVID-19 DNA Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global COVID-19 DNA Vaccine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global COVID-19 DNA Vaccine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America COVID-19 DNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe COVID-19 DNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia COVID-19 DNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America COVID-19 DNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa COVID-19 DNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 30. LineaRx Corporate Summary
Table 31. LineaRx COVID-19 DNA Vaccine Product Offerings
Table 32. LineaRx COVID-19 DNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 33. Inovio Pharmaceuticals Corporate Summary
Table 34. Inovio Pharmaceuticals COVID-19 DNA Vaccine Product Offerings
Table 35. Inovio Pharmaceuticals COVID-19 DNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 36. Zydus Cadila Corporate Summary
Table 37. Zydus Cadila COVID-19 DNA Vaccine Product Offerings
Table 38. Zydus Cadila COVID-19 DNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 39. Kangtai Biological Corporate Summary
Table 40. Kangtai Biological COVID-19 DNA Vaccine Product Offerings
Table 41. Kangtai Biological COVID-19 DNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 42. Advaccine Corporate Summary
Table 43. Advaccine COVID-19 DNA Vaccine Product Offerings
Table 44. Advaccine COVID-19 DNA Vaccine Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. COVID-19 DNA Vaccine Segment by Type
Figure 2. COVID-19 DNA Vaccine Segment by Application
Figure 3. Global COVID-19 DNA Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global COVID-19 DNA Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global COVID-19 DNA Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COVID-19 DNA Vaccine Revenue in 2020
Figure 8. By Type - Global COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 9. By Application - Global COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 10. By Region - Global COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 11. By Country - North America COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 12. US COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 16. Germany COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 17. France COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 24. China COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. India COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 30. Brazil COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa COVID-19 DNA Vaccine Revenue Market Share, 2016-2027
Figure 33. Turkey COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE COVID-19 DNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. LineaRx COVID-19 DNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Inovio Pharmaceuticals COVID-19 DNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Zydus Cadila COVID-19 DNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Kangtai Biological COVID-19 DNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications